Literature DB >> 3449380

Influence of probenecid on the urinary excretion rates of the diastereomeric benoxaprofen glucuronides.

H Spahn1, S Iwakawa, L Z Bevet, E T Lin.   

Abstract

A major biotransformation pathway for many NSAIDs from the group of optically active 2-arylpropionic acids is the conjugation with D-glucuronic acid, forming diastereomers. These conjugates of the S-(+)-and the R-(-)-enantiomers can be separated directly, e.g., by ion-pair chromatography on a C18-column using a mixture of tetrabutylammonium buffer pH 2.5 and acetonitrile as mobile phase. In man about 40% of the dose was recovered in urine as glucuronides (ratio S:R = 2.2) within 96 hours of p.o. administration of racemic drug. When probenecid, which is known to influence the elimination of several acidic drugs, was administered in addition, the amount excreted as glucuronides during 4 days was clearly reduced. Furthermore, the enantiomeric ratio was changed significantly, possibly because of an increase of stereoinversion due to the reduced drug clearance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3449380     DOI: 10.1007/BF03189905

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  8 in total

1.  The stereoselective uptake of ibuprofen enantiomers into adipose tissue.

Authors:  K Williams; R Day; R Knihinicki; A Duffield
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

2.  Activated alpha-alkyl-alpha-arylacetic acid enantiomers for stereoselective thin-layer chromatographic and high-performance liquid chromatographic determination of chiral amines.

Authors:  H Weber; H Spahn; E Mutschler; W Möhrke
Journal:  J Chromatogr       Date:  1984-04-13

3.  Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformate.

Authors:  S Björkman
Journal:  J Chromatogr       Date:  1985-05-03

4.  Clinical pharmacology of benoxaprofen.

Authors:  A S Ridolfo; R H Carmichael; K A DeSante; R F Bergstrom; F W Rockhold; J F Nash; S E Fineberg
Journal:  Eur J Rheumatol Inflamm       Date:  1982

5.  Pharmacokinetic studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetic and metabolic studies.

Authors:  J F Nash; R H Carmichael; A S Ridolfo; C T Spradlin
Journal:  J Rheumatol Suppl       Date:  1980

6.  Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.

Authors:  P C Smith; P N Langendijk; J A Bosso; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1985-08       Impact factor: 6.875

7.  Stereospecific inversion of (R)-(-)-benoxaprofen in rat and man.

Authors:  R G Simmonds; T J Woodage; S M Duff; J N Green
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

8.  Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. I. 2-Phenylpropionic acid disposition.

Authors:  P J Meffin; B C Sallustio; Y J Purdie; M E Jones
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

  8 in total
  6 in total

Review 1.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

3.  Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.

Authors:  T B Vree; E W Beneken Kolmer
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

4.  The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.

Authors:  P J Hayball; R L Nation; F Bochner; L N Sansom; M J Ahern; M D Smith
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

5.  Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.

Authors:  J I Macdonald; S M Wallace; R J Herman; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1992-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.